These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2110878)

  • 1. Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ansorg R; Müller KD; Wiora J
    Chemotherapy; 1990; 36(3):222-9. PubMed ID: 2110878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
    Khan M; Ma K; Wan I; Willcox MD
    Cont Lens Anterior Eye; 2023 Jun; 46(3):101819. PubMed ID: 36732125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
    Kumar A; Hay MB; Maier GA; Dyke JW
    J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the inoculum concentration on the in vitro sensitivity of Pseudomonas aeruginosa].
    Zarakolu P; Cöplü N; Güvener E
    Mikrobiyol Bul; 1993 Jul; 27(3):211-5. PubMed ID: 8361409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
    Wu YL; Scott EM; Po AL; Tariq VN
    APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
    Sofianou DC; Douboyas JP
    J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS; Neu HC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Pfaller M; Bale M; Preston T; Howard W; Koontz F
    Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Pseudomonas aeruginosa from bacteremic and fibrocystic patients to four quinolones and five other antipseudomonal antibiotics.
    Lester A; Andreasen JJ
    Scand J Infect Dis; 1988; 20(5):525-9. PubMed ID: 3146807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Shawar RM; MacLeod DL; Garber RL; Burns JL; Stapp JR; Clausen CR; Tanaka SK
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2877-80. PubMed ID: 10582875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.
    Bonfiglio G; Carciotto V; Russo G; Stefani S; Schito GC; Debbia E; Nicoletti G
    J Antimicrob Chemother; 1998 Feb; 41(2):307-10. PubMed ID: 9533479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
    Ronco E; Vacheron F; Orabona A
    Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F; Quentin C
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
    Fernandes CJ; Stevens DA; Ackerman VP
    Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents.
    Davidson S; Lipshitz M; Bogokowski B; Rubinstein E
    Isr J Med Sci; 1982 Aug; 18(8):859-62. PubMed ID: 6811501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.